Gene Study of Cancer Tissue to Predict Treatment Outcomes
Treatments studied
Part of Cancer clinical trials.
This study analyzes genetic information from cancer tumor samples to understand how genes affect treatment response and survival. By looking at leftover tissue or blood samples, researchers hope to better predict which treatments might work best for individual patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were treated at Nanfang Hospital between January 2017 and December 2025
- You have a cancer diagnosis
- Your doctor rates your overall health and activity level as 0–2 on a standard scale (you can do light activities or bed rest)
- Leftover tumor tissue samples (from biopsy or surgery) or blood samples are available for genetic testing
- You are willing to sign consent and participate voluntarily
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genetic information (DNA) from your blood and from saved tumor tissue to better understand certain cancers, especially rare cancers with a poor outlook. It may help researchers learn why these cancers behave the way they do and guide future treatments.
This study looks at stored tumor samples to understand why some people respond much better or much worse than expected. The goal is to learn what the tumor’s genes might be telling doctors about response to treatment.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
This trial uses advanced gene sequencing technology on blood and tumor tissue samples from people with non-small cell lung cancer. The goal is to see if this testing can help doctors better predict which treatments will work and detect if the cancer comes back early.
This study analyzes genetic information from blood samples in patients with advanced lung cancer, head and neck cancer, or mesothelioma who are starting chemotherapy and immunotherapy. Understanding your cancer's genetics may help doctors personalize treatment and improve outcomes.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
Hear when a new Malignant Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.